Immunomodulatory Therapy for the Management of Loiasis

Clin Infect Dis. 2021 Oct 5;73(7):e1632-e1633. doi: 10.1093/cid/ciaa1367.

Authors

Christina Coyle¹, Louis M Weiss^{1

2}

Affiliations

¹ Division of Infectious Diseases, Department of Medicine, Albert Einstein College of Medicine, Bronx, New, York, USA.
² Department of Pathology, Albert Einstein College of Medicine, Bronx, New York, USA.

PMID: 33326992
DOI: 10.1093/cid/ciaa1367

No abstract available

Keywords: IgE; IL-5; adverse reactions; diethylcarbamazine (DEC); immune modulation; loiasis; reslizumab; therapy.

Publication types

Editorial
Comment

MeSH terms

Diethylcarbamazine
Filaricides* / therapeutic use
Humans
Immunomodulation
Loiasis* / drug therapy

Substances

Filaricides
Diethylcarbamazine